All In Biotech

Drug Trial Radar · NCT03182634

The UK Plasma Based Molecular Profiling of Advanced Breast Cancer to Inform Therapeutic CHoices (plasmaMATCH) Trial

A Multiple Parallel Cohort, Multi-centre Phase IIa Trial Aiming to Provide Proof of Principle Efficacy for Designated Targeted Therapies in Patients With Advanced Breast Cancer Where the Targetable Mutation is Identified Through ctDNA

Last checked: Nov 19, 2026Latest source record: Jan 22, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

1,150

Planned (sponsor's estimate)

Start

Dec 15, 2016

Primary completion

Nov 2022

Study completion Nov 2023

Sponsor

Lead sponsor
Institute of Cancer Research, United KingdomAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Royal Marsden NHS Foundation Trust
First posted
Jun 9, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Other
FDA-regulated drug
No
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

plasmaMATCH is a multi-centre phase IIa umbrella trial platform consisting of a ctDNA screening component and a therapeutic component. plasmaMATCH aims to assess whether ctDNA screening can be used to detect patient subgroups who will be sensitive to targeted therapies, and will also assess the safety and activity of the targeted treatments.

Conditions

  • Advanced Breast Cancer

Interventions

  • FulvestrantDrug

  • NeratinibDrug

  • AZD5363Drug

  • OlaparibDrug

  • AZD6738Drug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The primary endpoint for Cohorts A to E is confirmed objective response rate as defined by RECIST v1.1 for each cohort separatelyTime frame: up to 24 weeks

Locations

19 sites in 1 country. Site status is shown where the registry gives one.

  • Royal Bournemouth Hospital

    Bournemouth, United Kingdom · Recruiting

  • Bristol Haematology and Oncology Centre

    Bristol, United Kingdom · Recruiting

  • Addenbrooke's Hospital

    Cambridge, United Kingdom · Recruiting

  • Velindre Cancer Centre

    Cardiff, United Kingdom · Recruiting

  • Western General Hospital

    Edinburgh, United Kingdom · Recruiting

  • Royal Devon and Exeter Hospital

    Exeter, United Kingdom · Recruiting

  • Beatson West of Scotland Cancer Centre

    Glasgow, United Kingdom · Recruiting

  • Clatterbridge Cancer Centre

    Liverpool, United Kingdom · Recruiting

  • Barts Health Trust

    London, United Kingdom · Recruiting

  • Royal Marsden Hospital

    London, United Kingdom · Recruiting

  • University College Hospital London

    London, United Kingdom · Recruiting

  • Kent Oncology Centre

    Maidstone, United Kingdom · Recruiting

  • Christie Hospital

    Manchester, United Kingdom · Recruiting

  • Churchill Hospital

    Oxford, United Kingdom · Recruiting

  • Derriford Hospital

    Plymouth, United Kingdom · Recruiting

  • Weston Park Hospital

    Sheffield, United Kingdom · Recruiting

  • University Hospitals Southampton NHS Foundation Trust

    Southampton, United Kingdom · Recruiting

  • Royal Cornwall Hospital

    Truro, United Kingdom · Recruiting

  • Royal Marsden Hosital

    Sutton, England, United Kingdom · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.